VYGR

Voyager Therapeutics, Inc.

8.10 USD
-0.13 (-1.58%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Voyager Therapeutics, Inc. stock is up 4.25% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 CALLs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 Apr 14:56 18 Oct, 2024 7.50 CALL 75 238
01 Apr 17:10 18 Oct, 2024 7.50 CALL 75 238

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease.

  • HC Wainwright & Co.
    Thu May 16, 13:28
    buy
    confirm
  • Oppenheimer
    Wed May 15, 11:39
    buy
    confirm
  • Wedbush
    Tue May 14, 08:31
    hold
    confirm